These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21371907)

  • 21. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccinated fish welfare: protection versus side-effects.
    Midtlyng PJ
    Dev Biol Stand; 1997; 90():371-9. PubMed ID: 9270866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice.
    Coecke S; Balls M; Bowe G; Davis J; Gstraunthaler G; Hartung T; Hay R; Merten OW; Price A; Schechtman L; Stacey G; Stokes W;
    Altern Lab Anim; 2005 Jun; 33(3):261-87. PubMed ID: 16180980
    [No Abstract]   [Full Text] [Related]  

  • 24. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.
    Stokes W; McFarland R; Kulpa-Eddy J; Gatewood D; Levis R; Halder M; Pulle G; Kojima H; Casey W; Gaydamaka A; Miller T; Brown K; Lewis C; Chapsal JM; Bruckner L; Gairola S; Kamphuis E; Rupprecht CE; Wunderli P; McElhinney L; De Mattia F; Gamoh K; Hill R; Reed D; Doelling V; Johnson N; Allen D; Rinckel L; Jones B
    Biologicals; 2012 Sep; 40(5):369-81. PubMed ID: 22884673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduction of animal experiments in experimental drug testing].
    Behrensdorf-Nicol H; Krämer B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1173-80. PubMed ID: 25183445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement, reduction and refinement.
    Flecknell P
    ALTEX; 2002; 19(2):73-8. PubMed ID: 12098013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Good cell culture practice (GCCP)--an initiative for standardization and quality control of in vitro studies. The establishment of an ECVAM Task Force on GCCP].
    Hartung T; Gstraunthaler G; Coecke S; Lewis D; Blanck O; Balls M
    ALTEX; 2001; 18(1):75-8. PubMed ID: 11248855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fish as research tools: alternatives to in vivo experiments.
    Schaeck M; Van den Broeck W; Hermans K; Decostere A
    Altern Lab Anim; 2013 Jul; 41(3):219-29. PubMed ID: 23971702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers.
    Schiffelers MJ; Blaauboer B; Bakker W; Hendriksen C
    Biologicals; 2014 Jul; 42(4):205-17. PubMed ID: 24837056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal use replacement, reduction, and refinement: development of an integrated testing strategy for bioconcentration of chemicals in fish.
    de Wolf W; Comber M; Douben P; Gimeno S; Holt M; Léonard M; Lillicrap A; Sijm D; van Egmond R; Weisbrod A; Whale G
    Integr Environ Assess Manag; 2007 Jan; 3(1):3-17. PubMed ID: 17283592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Batch safety testing of veterinary vaccines - potential welfare implications of injection volumes.
    Cooper J
    Altern Lab Anim; 2008 Dec; 36(6):685-94. PubMed ID: 19154094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 4R concept for the safety testing of immunobiologicals.
    Cussler K
    Dev Biol Stand; 1999; 101():121-6. PubMed ID: 10566784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.